Maize transformation enhancer discovery through biparental mapping of WUS/BBM modifier genes

Technology
In development
University

Research platform for identifying novel morphogenic genes that enhance WUSCHEL/BABYBOOM-mediated plant transformation across recalcitrant maize genotypes. Leverages introgression line fine-mapping and candidate gene screening to overcome genotype-dependent bottlenecks in crop biotechnology.

Overview

This research program addresses one of the most persistent bottlenecks in crop biotechnology: the genotype-dependence of plant transformation. While WUSCHEL/BABYBOOM (WUS/BBM)-mediated transformation has emerged as a breakthrough enabling genotype-flexible plant regeneration, transformation efficiency can vary dramatically from less than 1% to over 100% depending on the genetic background. This program applies biparental mapping and introgression line analysis to identify modifier genes that can boost WUS/BBM performance across recalcitrant crop varieties.

The value proposition for industry partners is significant: improved transformation efficiency in difficult genotypes accelerates trait development pipelines, reduces costs, and expands the range of commercially important cultivars that can be engineered. By identifying the genetic factors controlling transformation responsiveness, this work enables more predictable, scalable plant biotechnology workflows for maize and potentially other crops.

Technical specifications

Mapping and discovery platform:

  • Biparental mapping population developed from a highly WUS/BBM-responsive maize genotype (80% transformation efficiency) crossed with B73, a recalcitrant inbred (4% efficiency)
  • Introgression library of over 50 lines generated through marker-assisted backcrossing using SSR markers
  • Seven amenable introgression lines identified, with three retaining overlapping introgressions from the responsive donor parent
  • PacBio high-quality sequencing to generate precise maps of introgression boundaries
  • RNA-Seq analysis to narrow candidate gene lists
  • Golden Gate cloning system for rapid synthesis of constitutive expression vectors
  • Functional screening pipeline using WUS/BBM transformation to validate candidate genes

Prior validation track record:

The team has previously identified a novel morphogenic regulator from the A188 maize line that induces somatic embryogenesis in recalcitrant B73, demonstrating the feasibility of this gene discovery approach. The established pipeline covers QTL identification, gene model evaluation through transcriptomic studies, and functional testing in B73.

Technology readiness level

The program is at an advanced discovery stage with validated methodology. The mapping population has been constructed, responsive and recalcitrant parents have been characterized, and initial screening has identified promising introgression lines with overlapping donor segments. Current funding needs support PacBio sequencing for high-resolution introgression mapping and synthesis of candidate gene parts for functional validation. The next milestones include refined candidate gene identification through RNA-Seq, vector construction, and high-throughput screening through WUS/BBM transformation. Upon successful gene identification, the technology would advance toward trait deployment applications in maize breeding and biotechnology programs.


About University of Wisconsin, Madison

The University of Wisconsin–Madison is the state’s flagship public research university, a comprehensive institution with a large research enterprise and broad disciplinary breadth. Industry engages through shared instrumentation, pilot‑scale testbeds, and co-located core facilities that support prototyping and scale-up. An affiliated research and technology park hosts startups and corporate R&D, while integration with a major hospital system enables clinical translation; a statewide extension network connects campus advances to companies and communities across Wisconsin. Research is sustained by competitive federal funding from agencies such as NIH, NSF, DOE, USDA, and DoD, alongside state and industry partnerships. Dedicated commercialization support—through an affiliated foundation and campus offices—provides IP management, licensing, startup mentoring, and flexible, industry-friendly agreements.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.